Your browser doesn't support javascript.
loading
Longitudinal poly- and perfluoroalkyl substances (PFAS) levels in Dutch infants.
van Beijsterveldt, Inge A L P; van Zelst, Bertrand D; van den Berg, Sjoerd A A; de Fluiter, Kirsten S; van der Steen, Manouk; Hokken-Koelega, Anita C S.
Afiliação
  • van Beijsterveldt IALP; Department of Pediatrics, Subdivision of Endocrinology, Erasmus University Medical Center /Sophia Children's Hospital, Rotterdam, the Netherlands. Electronic address: i.vanbeijsterveldt@erasmusmc.nl.
  • van Zelst BD; Diagnostic Laboratory of Endocrinology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • van den Berg SAA; Diagnostic Laboratory of Endocrinology, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • de Fluiter KS; Department of Pediatrics, Subdivision of Endocrinology, Erasmus University Medical Center /Sophia Children's Hospital, Rotterdam, the Netherlands.
  • van der Steen M; Dutch Growth Research Foundation, Rotterdam, the Netherlands.
  • Hokken-Koelega ACS; Department of Pediatrics, Subdivision of Endocrinology, Erasmus University Medical Center /Sophia Children's Hospital, Rotterdam, the Netherlands; Dutch Growth Research Foundation, Rotterdam, the Netherlands.
Environ Int ; 160: 107068, 2022 02.
Article em En | MEDLINE | ID: mdl-34968992
ABSTRACT
BACKGROUND AND

AIMS:

Per- and polyfluoroalkyl substances (PFAS) are a potential hazard for public health. These man-made-chemicals are non-degradable with an elimination half-life of multiple years, causing accumulation in the environment and humans. Rodent studies demonstrated that PFAS are harmful, especially when present during the critical window in the first months of life. Because longitudinal data during infancy are limited, we investigated longitudinal plasma levels in infants aged 3 months and 2 years and its most important determinants.

METHODS:

In 369 healthy term-born Dutch infants, we determined plasma PFOS, PFOA, PFHxS, PFNA and PFDA levels at age 3 months and 2 years, using liquid chromatography-electrospray-ionization-tandem-mass-spectrometry (LC-ESI-MS/MS). We studied the associations with maternal and child characteristics by multiple regression models.

RESULTS:

At age 3 months, median plasma levels of PFOS, PFOA, PFHxS, PFNA and PFDA were 1.48, 2.40, 0.43, 0.23 and 0.07 ng/mL, resp. Levels decreased slightly until age 2 years to 1.30, 1.81, 0.40, 0.21 and 0.08 ng/mL, resp. Maternal age, first born, Caucasian ethnicity and exclusive breastfeeding were associated with higher infant's plasma levels at age 3 months. Levels at 3 months were the most important predictor for PFAS levels at age 2 years. Infants with exclusive breastfeeding during the first 3 months of life (EBF) had 2-3 fold higher levels throughout infancy compared to infants with exclusive formula feeding (EFF), with PFOA levels at 3 months 3.72 ng/mL versus 1.26 ng/mL and at 2 years 3.15 ng/mL versus 1.22 ng/mL, respectively.

CONCLUSION:

Plasma PFAS levels decreased only slightly during infancy. Higher levels at age 3 months were found in Caucasian, first-born infants from older mothers and throughout infancy in EBF-infants. Our findings indicate that trans-placental transmission and breastfeeding are the most important determinants of PFAS exposure in early life.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácidos Alcanossulfônicos / Poluentes Ambientais / Fluorocarbonos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Environ Int Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácidos Alcanossulfônicos / Poluentes Ambientais / Fluorocarbonos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Environ Int Ano de publicação: 2022 Tipo de documento: Article